ATE353921T1 - Chimäre polypeptide, verfahren zur herstellung und verwendung dafür - Google Patents
Chimäre polypeptide, verfahren zur herstellung und verwendung dafürInfo
- Publication number
- ATE353921T1 ATE353921T1 AT00948017T AT00948017T ATE353921T1 AT E353921 T1 ATE353921 T1 AT E353921T1 AT 00948017 T AT00948017 T AT 00948017T AT 00948017 T AT00948017 T AT 00948017T AT E353921 T1 ATE353921 T1 AT E353921T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- chimeric polypeptides
- chimeric
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/624—Disulfide-stabilized antibody (dsFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22023—Virus like particles [VLP]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99115022A EP1074563A1 (de) | 1999-08-02 | 1999-08-02 | Erhöhte Bildung von Chimären Polypeptiden durch Ausbildung von Dimeren mittels elektrostatischen wechselwirkungen und Disulfidbindungen sowie Verfahren zur Herstellung und Anwendungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE353921T1 true ATE353921T1 (de) | 2007-03-15 |
Family
ID=8238697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00948017T ATE353921T1 (de) | 1999-08-02 | 2000-07-31 | Chimäre polypeptide, verfahren zur herstellung und verwendung dafür |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6437095B1 (de) |
| EP (2) | EP1074563A1 (de) |
| JP (1) | JP4011914B2 (de) |
| KR (1) | KR100484084B1 (de) |
| CN (1) | CN1184235C (de) |
| AR (1) | AR021448A1 (de) |
| AT (1) | ATE353921T1 (de) |
| AU (1) | AU768645B2 (de) |
| BR (1) | BR0012926A (de) |
| CA (1) | CA2380569C (de) |
| DE (1) | DE60033405T2 (de) |
| DK (1) | DK1206495T3 (de) |
| ES (1) | ES2280231T3 (de) |
| MX (1) | MXPA02001139A (de) |
| TR (1) | TR200200252T2 (de) |
| WO (1) | WO2001009193A1 (de) |
| ZA (1) | ZA200109746B (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192596B2 (en) * | 1996-08-23 | 2007-03-20 | The Health Protection Agency Ipsen Limited | Recombinant toxin fragments |
| US20030157091A1 (en) * | 2002-02-14 | 2003-08-21 | Dyax Corporation | Multi-functional proteins |
| US7335361B2 (en) * | 2003-06-09 | 2008-02-26 | Animal Technology Institute Taiwan | Fusion antigen used as vaccine |
| US7348399B2 (en) * | 2003-08-29 | 2008-03-25 | Louisiana Tech University Foundation, Inc. | Nanofabricated polypeptide multilayer films, coatings, and microcapsules |
| US7550557B2 (en) | 2003-08-29 | 2009-06-23 | Louisiana Tech University Foundation, Inc. | Multilayer films, coatings, and microcapsules comprising polypeptides |
| US7544770B2 (en) * | 2003-08-29 | 2009-06-09 | Louisiana Tech Foundation, Inc. | Multilayer films, coatings, and microcapsules comprising polypeptides |
| JP2008520661A (ja) * | 2004-11-22 | 2008-06-19 | ルイジアナ テク ユニバーシティ ファウンデーション | 静電積層自己組織化(ElectrostaticLayer−by−LayerSelfAssembly)による薄膜、コーティング、およびマイクロカプセルの微細製造(nanofabrication)のための、ポリペプチドの設計法 |
| US20090246127A1 (en) * | 2004-12-17 | 2009-10-01 | Koninklijke Philips Electronics, N.V. | Targeting agents for molecular imaging |
| CN102712696A (zh) | 2009-09-16 | 2012-10-03 | 弗·哈夫曼-拉罗切有限公司 | 包含卷曲螺旋和/或系链的蛋白质复合体及其用途 |
| TW201138821A (en) | 2010-03-26 | 2011-11-16 | Roche Glycart Ag | Bispecific antibodies |
| CA2817455C (en) | 2010-12-23 | 2019-04-16 | F. Hoffmann-La Roche Ag | Detection of a polypeptide dimer by a bivalent binding agent |
| EP2659269B1 (de) | 2010-12-23 | 2016-10-26 | Roche Diagniostics GmbH | Erkennung von posttranslational modifiziertem polypeptid durch ein bivalentes bindungsmolekül |
| CN103384681B (zh) | 2010-12-23 | 2018-05-18 | 霍夫曼-拉罗奇有限公司 | 结合剂 |
| EP2655413B1 (de) | 2010-12-23 | 2019-01-16 | F.Hoffmann-La Roche Ag | Polypeptid-polynukleotid-komplex und verwendung bei der gezielten effektorrest-bereitstellung |
| WO2012107932A1 (en) * | 2011-02-11 | 2012-08-16 | Transgene Biotek Ltd. | B cell clonal immunotoxin and use thereof |
| WO2012171996A1 (en) | 2011-06-15 | 2012-12-20 | F. Hoffmann-La Roche Ag | Anti-human epo receptor antibodies and methods of use |
| MX2014009565A (es) | 2012-02-10 | 2014-11-10 | Genentech Inc | Anticuerpos monocatenarios y otros heteromultimeros. |
| ES2597228T3 (es) | 2012-06-27 | 2017-01-17 | F. Hoffmann-La Roche Ag | Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas |
| CA2871386A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereof |
| KR20150030744A (ko) | 2012-06-27 | 2015-03-20 | 에프. 호프만-라 로슈 아게 | 표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Fc-영역 접합체의 제조 방법 및 그의 용도 |
| SG11201607818WA (en) | 2014-03-20 | 2016-10-28 | Bristol Myers Squibb Co | Stabilized fibronectin based scaffold molecules |
| PL3151921T3 (pl) | 2014-06-06 | 2020-02-28 | Bristol-Myers Squibb Company | Przeciwciała przeciwko receptorowi indukowanego glukokortykoidami czynnika martwicy nowotworu (gitr) i ich zastosowania |
| JP6805142B2 (ja) | 2014-11-21 | 2020-12-23 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | Cd73に対する抗体およびその使用 |
| JP6622814B2 (ja) | 2014-11-25 | 2019-12-18 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | イメージングのための新規pd−l1結合ポリペプチド |
| WO2016087416A1 (en) | 2014-12-03 | 2016-06-09 | F. Hoffmann-La Roche Ag | Multispecific antibodies |
| EP3233912B1 (de) | 2014-12-19 | 2021-05-19 | Regenesance B.V. | Antikörper zur bindung von humanem c6 und verwendungen davon |
| WO2016127052A1 (en) | 2015-02-05 | 2016-08-11 | Bristol-Myers Squibb Company | Cxcl11 and smica as predictive biomarkers for efficacy of anti-ctla4 immunotherapy |
| AU2016271111B2 (en) | 2015-05-29 | 2022-04-28 | Bristol-Myers Squibb Company | Antibodies against OX40 and uses thereof |
| EP3353198B1 (de) | 2015-09-23 | 2020-06-17 | Bristol-Myers Squibb Company | Glypican-3-bindende fibronektin-basierte gerüstmoleküle |
| MX2018006072A (es) | 2015-11-19 | 2018-08-01 | Squibb Bristol Myers Co | Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos. |
| AU2017228470A1 (en) | 2016-03-04 | 2018-08-30 | Bristol-Myers Squibb Company | Combination therapy with anti-CD73 antibodies |
| CN109562195A (zh) | 2016-06-01 | 2019-04-02 | 百时美施贵宝公司 | 用pd-l1结合多肽进行pet成像 |
| US20190248893A1 (en) | 2016-07-14 | 2019-08-15 | Bristol-Myers Squibb Company | Antibodies against tim3 and uses thereof |
| EP3535294B1 (de) | 2016-11-07 | 2025-02-12 | Neuracle Science Co., Ltd. | Anti-familie mit sequenzähnlichkeit 19, element a5-antikörper und verfahren zur verwendung davon |
| AR110755A1 (es) * | 2017-01-20 | 2019-05-02 | Genzyme Corp | Anticuerpos dirigidos a hueso |
| TW202506185A (zh) | 2017-01-20 | 2025-02-16 | 法商賽諾菲公司 | 抗TGF-β抗體及其用途 |
| JP7136790B2 (ja) | 2017-02-17 | 2022-09-13 | ブリストル-マイヤーズ スクイブ カンパニー | アルファ-シヌクレインに対する抗体およびその使用 |
| BR112019027729A2 (pt) | 2017-06-27 | 2020-08-18 | Neuracle Science Co., Ltd | anticorpos anti-fam19a5 e seus usos |
| JP7358361B2 (ja) | 2018-01-12 | 2023-10-10 | ブリストル-マイヤーズ スクイブ カンパニー | Tim3に対する抗体およびその使用 |
| JP7351845B2 (ja) | 2018-03-23 | 2023-09-27 | ブリストル-マイヤーズ スクイブ カンパニー | Micaおよび/またはmicbに対する抗体ならびにそれらの使用 |
| CR20250022A (es) | 2018-04-02 | 2025-02-25 | Bristol Myers Squibb Co | Anticuerpos anti-trem-1, ácidos nucleicos y vectores de los mismos (divisional 2020-0450) |
| MX2020013923A (es) | 2018-06-29 | 2021-03-29 | Apitbio Inc | Anticuerpos anti molécula de adhesión celular l1 (l1cam) y usos de estos. |
| MX2021004504A (es) | 2019-01-02 | 2021-10-01 | Neuracle Science Co Ltd | Anti-familia con similitud de secuencia 19, anticuerpos del miembro a5 y método de uso de los mismos. |
| CN118894938A (zh) | 2019-01-22 | 2024-11-05 | 百时美施贵宝公司 | 抗IL-7Rα亚基的抗体及其用途 |
| WO2020221153A1 (zh) * | 2019-04-28 | 2020-11-05 | 广州市雷德生物科技有限公司 | 一种促进蛋白二聚体形成的拉链扣结构及其应用 |
| EP3999541A1 (de) | 2019-07-15 | 2022-05-25 | Bristol-Myers Squibb Company | Antikörper gegen menschlichen trem-1 und ihre verwendungen |
| WO2021011678A1 (en) | 2019-07-15 | 2021-01-21 | Bristol-Myers Squibb Company | Anti-trem-1 antibodies and uses thereof |
| CN112694527B (zh) * | 2020-12-25 | 2022-09-09 | 山东睿鹰制药集团有限公司 | 一种重组人干扰素-κ包涵体的纯化和复性方法 |
| JP2024514530A (ja) | 2021-04-02 | 2024-04-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 切断型cdcp1に対する抗体およびその使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK132892D0 (da) * | 1992-10-30 | 1992-10-30 | Novo Nordisk As | Proteiner |
| US5747654A (en) * | 1993-06-14 | 1998-05-05 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| EP0979281B1 (de) * | 1997-05-02 | 2005-07-20 | Genentech, Inc. | ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen |
-
1999
- 1999-08-02 EP EP99115022A patent/EP1074563A1/de not_active Withdrawn
-
2000
- 2000-07-24 AR ARP000103808A patent/AR021448A1/es active IP Right Grant
- 2000-07-26 US US09/625,570 patent/US6437095B1/en not_active Expired - Lifetime
- 2000-07-31 TR TR2002/00252T patent/TR200200252T2/xx unknown
- 2000-07-31 DK DK00948017T patent/DK1206495T3/da active
- 2000-07-31 CA CA002380569A patent/CA2380569C/en not_active Expired - Fee Related
- 2000-07-31 KR KR10-2002-7001377A patent/KR100484084B1/ko not_active Expired - Fee Related
- 2000-07-31 BR BR0012926-7A patent/BR0012926A/pt not_active IP Right Cessation
- 2000-07-31 AU AU61610/00A patent/AU768645B2/en not_active Ceased
- 2000-07-31 ES ES00948017T patent/ES2280231T3/es not_active Expired - Lifetime
- 2000-07-31 CN CNB008095159A patent/CN1184235C/zh not_active Expired - Fee Related
- 2000-07-31 AT AT00948017T patent/ATE353921T1/de active
- 2000-07-31 DE DE60033405T patent/DE60033405T2/de not_active Expired - Lifetime
- 2000-07-31 WO PCT/EP2000/007378 patent/WO2001009193A1/en not_active Ceased
- 2000-07-31 JP JP2001513999A patent/JP4011914B2/ja not_active Expired - Lifetime
- 2000-07-31 MX MXPA02001139A patent/MXPA02001139A/es active IP Right Grant
- 2000-07-31 EP EP00948017A patent/EP1206495B1/de not_active Expired - Lifetime
-
2001
- 2001-11-27 ZA ZA200109746A patent/ZA200109746B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100484084B1 (ko) | 2005-04-20 |
| WO2001009193A1 (en) | 2001-02-08 |
| EP1206495A1 (de) | 2002-05-22 |
| CA2380569C (en) | 2008-01-22 |
| JP2003506028A (ja) | 2003-02-18 |
| AU768645B2 (en) | 2003-12-18 |
| DE60033405D1 (de) | 2007-03-29 |
| US6437095B1 (en) | 2002-08-20 |
| EP1074563A1 (de) | 2001-02-07 |
| AR021448A1 (es) | 2002-07-17 |
| ES2280231T3 (es) | 2007-09-16 |
| DE60033405T2 (de) | 2007-10-31 |
| CA2380569A1 (en) | 2001-02-08 |
| DK1206495T3 (da) | 2007-06-11 |
| ZA200109746B (en) | 2003-03-12 |
| MXPA02001139A (es) | 2002-08-20 |
| CN1184235C (zh) | 2005-01-12 |
| JP4011914B2 (ja) | 2007-11-21 |
| EP1206495B1 (de) | 2007-02-14 |
| CN1358198A (zh) | 2002-07-10 |
| BR0012926A (pt) | 2002-04-30 |
| TR200200252T2 (tr) | 2002-05-21 |
| AU6161000A (en) | 2001-02-19 |
| KR20020026558A (ko) | 2002-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60033405D1 (de) | Chimäre polypeptide, verfahren zur herstellung und verwendung dafür | |
| DE60018805D1 (de) | Oberflächenmodifiziertes anorganisches oxidpulver, verfahren zur herstellung desselben und verwendung desselben | |
| DE60027721D1 (de) | Bodenbelag, giessform und verfahren zur herstellung derselben | |
| DE69921099D1 (de) | Wärmeausdehnbare mikrokapseln, verfahren zur herstellung und verwendung derselben | |
| DE69812341D1 (de) | Poröse gesinterte kunststoffprodukte und verfahren zur herstellung | |
| DE59813187D1 (de) | Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung | |
| DE69911549D1 (de) | Wässrige zusammensetzung, wässrige schneidfluid, verfahren zur herstellung und zur verwendung | |
| DE69916873D1 (de) | Piezo tintenstrahltinten und verfahren zur herstellung und verwendung derselben | |
| ATE208628T1 (de) | Neue antithrombotische formulierung, verfahren zur herstellung und gebrauch davon | |
| DE69917716D1 (de) | Protein-deamiderendes Enzym, dafür kodierendes Gen, Verfahren zur Herstellung und Verwendung davon | |
| DE69936005D1 (de) | Mehrschichtverpackungsmaterial und verfahren zur herstellung desselben | |
| DE69835139D1 (de) | Fäulnisverhindernde emulsionsbeschichtungszusammensetzung, verfahren zur herstellung und mit dieser fäulnisverhindernden zusammensetzung beschichteter gegenstand | |
| DE69725329D1 (de) | Richtungsweisende markierung mit hervortretenden erhebungen und verfahren zur herstellung | |
| DE60045480D1 (de) | Druckempfindliches klebeband und verfahren zur herstellung desselben | |
| DE69941954D1 (de) | Oxetanderivate, oxetancopolymer, und verfahren zur herstellung von oxetanderivaten | |
| EP1576108A4 (de) | Nitrilasen, diese codierende nukleinsäuren sowie verfahren zur herstellung und verwendung davon | |
| DE69903631D1 (de) | Beschichtungszusammensetzung, verfahren zur herstellung und kratzfeste kunststofflinse | |
| DE69931946D1 (de) | Zusammensetzungen und verfahren zur zubereitung von dispersionen und verfahren zur verwendung der dispersionen | |
| DE60213444D1 (de) | Fluorpolymerlaminate und verfahren zur herstellung derselben | |
| DE69812365D1 (de) | Enthaarungsmitteln, verfahren zur herstellung sowie ihre verwendung | |
| EP0585464A4 (de) | Stark wasserabdorbierender reis, verfahren zur dessen herstellung und verwendung. | |
| ATE258558T1 (de) | Lantibiotikum verwandt mit actagardine, verfahren zur herstellung und verwendung desselben | |
| DE60133124D1 (de) | Poröses schallschluckendes material und verfahren zur herstellung desselben | |
| DE68917154D1 (de) | C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung. | |
| DE50104838D1 (de) | Keramikmasse, verfahren zur herstellung der keramikmasse und verwendung der keramikmasse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1206495 Country of ref document: EP |